Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract. 2017 Dec; 23(8):575-581.